Recent findings also indicate that prebiotic modulation of intestinal microflora improved metabolic impairments, plasma and hepatic inflammation during obesity and diabetes via increased glucagon-like peptide-2 (GLP-2) [78]. The gene discussed is GCG; the disease is Obesity.